Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Shares, nominal value (euro)0.12 per share
-
Shares outstanding
-
67,811,197
-
Total 13F shares
-
10,142,925
-
Share change
-
+8,266,512
-
Total reported value
-
$212,493,000
-
Price per share
-
$20.95
-
Number of holders
-
18
-
Value change
-
+$173,182,000
-
Number of buys
-
17
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q4 2017
As of 31 Dec 2017,
InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,142,925 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., Cormorant Asset Management, LLC, Redmile Group, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., EVENTIDE ASSET MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.